AstraZeneca Pharma India Ltd. | Large-cap | Healthcare
₹8,907.00
1.81%
| AstraZeneca Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 17.2B
Gross Profit 7.5B 43.89%
Operating Income 2.1B 12.47%
Net Income 1.2B 6.74%
EPS (Diluted) ₹46.30

Balance Sheet Metrics

Total Assets 15.2B
Total Liabilities 7.5B
Shareholders Equity 7.7B
Debt to Equity 0.97

Cash Flow Metrics

Operating Cash Flow -2.3B
Free Cash Flow 636.1M

Revenue & Profitability Trend

AstraZeneca Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 17.2B 13.0B 10.0B 8.1B 8.1B
Cost of Goods Sold 9.6B 6.7B 4.3B 3.6B 3.3B
Gross Profit 7.5B 6.2B 5.8B 4.5B 4.8B
Operating Expenses 2.4B 1.9B 1.5B 1.3B 1.3B
Operating Income 2.1B 1.7B 1.5B 696.5M 1.2B
Pre-tax Income 1.6B 2.2B 1.3B 830.4M 1.3B
Income Tax 406.2M 580.3M 348.1M 214.4M 337.9M
Net Income 1.2B 1.6B 992.9M 616.0M 933.0M
EPS (Diluted) ₹46.30 ₹64.60 ₹39.70 ₹24.60 ₹37.30

Income Statement Trend

AstraZeneca Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 13.4B 9.3B 8.4B 7.1B 6.2B
Non-Current Assets 1.8B 1.5B 1.5B 1.5B 1.6B
Total Assets 15.2B 10.8B 9.8B 8.6B 7.7B
Liabilities
Current Liabilities 7.0B 3.6B 3.8B 3.3B 3.0B
Non-Current Liabilities 447.7M 89.9M 122.5M 125.2M 150.4M
Total Liabilities 7.5B 3.7B 4.0B 3.5B 3.2B
Equity
Total Shareholders Equity 7.7B 7.1B 5.9B 5.1B 4.6B

Balance Sheet Composition

AstraZeneca Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 1.6B 2.2B 1.3B 830.4M 1.3B
Operating Cash Flow -2.3B 932.3M 501.3M 902.8M 1.5B
Investing Activities
Capital Expenditures -10.4M -103.5M -50.4M -63.7M -52.9M
Investing Cash Flow -10.4M -103.5M -50.4M -63.7M 1.6B
Financing Activities
Dividends Paid -600.0M -400.0M -200.0M -50.0M -50.0M
Financing Cash Flow -600.0M -400.0M -200.0M -50.0M -50.0M
Free Cash Flow 636.1M 171.1M 497.7M 911.8M 970.7M

Cash Flow Trend

AstraZeneca Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 190.83
Price to Book 28.59
Price to Sales 12.84
PEG Ratio -6.74

Profitability Ratios

Profit Margin 6.74%
Operating Margin 14.29%
Return on Equity 15.62%
Return on Assets 10.30%

Financial Health

Current Ratio 1.91
Debt to Equity 4.64
Beta 0.03

Per Share Data

EPS (TTM) ₹46.16
Book Value per Share ₹308.14
Revenue per Share ₹686.58

Financial data is updated regularly. All figures are in the company's reporting currency.